Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April L Risinger

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
EMBO Molecular Medicine|March 27, 2025
Beyond mitotic arrest: the diverse effects of microtubule-targeting drugs on tumor vasculatureApril L Risinger
Natural Product Reports|November 26, 2019
Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural productsApril L Risinger, Lin Du
Cancer Letters|November 3, 2009
Taccalonolides: Novel microtubule stabilizers with clinical potentialApril L Risinger, Susan L Mooberry
Cell Cycle (Georgetown, Tex.)|May 21, 2011
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxelApril L Risinger, Susan L Mooberry
Molecules (Basel, Switzerland)|July 19, 2021
Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer ModelsSamantha S Yee, April L Risinger
Molecular Biology of the Cell|April 25, 2008
Different ubiquitin signals act at the Golgi and plasma membrane to direct GAP1 traffickingApril L Risinger, Chris A Kaiser
Journal of Natural Products|March 6, 2019
Microtubule-Targeting Drugs: More than AntimitoticsRoma Kaul, April L Risinger, Susan L Mooberry
Progress in the Chemistry of Organic Natural Products|December 11, 2020
Taccalonolide Microtubule StabilizersSamantha S Yee, Lin Du, April L Risinger
British Journal of Cancer|October 16, 2020
Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
British Journal of Cancer|September 5, 2019
Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
EMBO Molecular Medicine|March 27, 2025
Beyond mitotic arrest: the diverse effects of microtubule-targeting drugs on tumor vasculatureApril L Risinger
Natural Product Reports|November 26, 2019
Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural productsApril L Risinger, Lin Du
Cancer Letters|November 3, 2009
Taccalonolides: Novel microtubule stabilizers with clinical potentialApril L Risinger, Susan L Mooberry
Cell Cycle (Georgetown, Tex.)|May 21, 2011
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxelApril L Risinger, Susan L Mooberry
Molecules (Basel, Switzerland)|July 19, 2021
Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer ModelsSamantha S Yee, April L Risinger
Molecular Biology of the Cell|April 25, 2008
Different ubiquitin signals act at the Golgi and plasma membrane to direct GAP1 traffickingApril L Risinger, Chris A Kaiser
Journal of Natural Products|March 6, 2019
Microtubule-Targeting Drugs: More than AntimitoticsRoma Kaul, April L Risinger, Susan L Mooberry
Progress in the Chemistry of Organic Natural Products|December 11, 2020
Taccalonolide Microtubule StabilizersSamantha S Yee, Lin Du, April L Risinger
British Journal of Cancer|October 16, 2020
Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
British Journal of Cancer|September 5, 2019
Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
Pageof 8